[1] 田耘博,冯凌,赵生银,等.《献血法》与相关法律法规的对比研究[J].临床输血与检验,2019,21(1):92-95. [2] 贾瑶瑶,胡伟,张光鹏,等.采供血机构人力资源配备标准的探索—基于浙江省调查数据[J].卫生经济研究,2021,38(11):59-63. [3] JONES J M,SAPIANO M R P,MOWLA S,et al.Has the trend of declining blood transfusions in the United States ended? Findings of the 2019 National Blood Collection and Utilization Survey[J].Transfusion,2021,61(Suppl 2):S1-S10. [4] 代华友,万建华,陈玉香,等.国内23家血液中心全血献血人群基本特征研究[J].中国输血杂志,2020,33(11):1122-1127. [5] 郭瑾,邱艳,王东梅,等. 我国大陆采供血机构执业比对指标的选择定义和意义[J].临床输血与检验,2017,19(1):17-22. [6] 邱艳,刘江.标杆管理在输血医学管理中的应用[J].临床输血与检验,2017,19(1):1-4. [7] 郭成城,邱艳,张娟,等.我国大陆采供血机构开展执业比对工作的现状[J].临床输血与检验,2017,19(1):4-7. [8] GERBER T,GIEZENDANNER S,ZELLER A.Measuring workload of Swiss general practice:a five-yearly questionnaire-based survey on general practitioners' self-reported working activities (2005-2020)[J].Swiss Med Wkly,2022,152:w30196. [9] TIMONY P,HOULE S K D,GAUTHIER A,et al.Geographic distribution of Ontario pharmacists:a focus on rural and northern communities[J].Can Pharm J (Ott),2022,155(5):267-276. [10] ROSE W N,DAYTON P J,RAIFE T J.An analysis of mobile whole blood collection labor efficiency[J].Transfusion,2011,51(7 Pt 2):1609-1612. [11] 邱艳,张新童,戚海,等.亚太血液联盟成员与大陆省级采供血机构部分执业指标比对结果比较分析[J].中国输血杂志,2020,33(11):1117-1122. [12] LIN C K,THOMAS S.Cost-effectiveness of blood programmes - the Asia Pacific Blood Network perspective[J].ISBT Sci Ser,2009,4(n2):332-336. [13] 李小春,王清,洪缨.四川省成分血制备现状[J].中国输血杂志,2019,32(11):1162-1165. [14] 夏晓,李燕红,李少华.浅谈现代化设备对血液成分制备工作的影响[J].中国卫生产业,2020,17(5):167-169. [15] 于洋,汪德清.输血科门诊建设与展望[J].中国输血杂志,2018,31(11):1217-1219. [16] ARCOT P J,KUMAR K,MUKHOPADHYAY T,et al.Potential challenges faced by blood bank services during COVID-19 pandemic and their mitigative measures:the Indian scenario[J].Transfus Apher Sci,2020,59(5):102877. [17] WANG Y J,HAN W J,PAN L L,et al.Impact of COVID-19 on blood centres in Zhejiang Province China[J].Vox Sang,2020,115(6):502-506. [18] AL-RIYAMI A Z,BURNOUF T,YAZER M,et al.International forum on the collection and use of COVID-19 convalescent plasma:protocols,challenges and lessons learned:summary[J].Vox Sang,2021,116(10):1117-1135. [19] AL-RIYAMI A Z,BURNOUF T,YAZER M,et al.International forum on the collection and use of COVID-19 convalescent plasma:responses[J].Vox Sang,2021,116(10):e71-e120. [20] Willis S,DE Corte K,Cairns J A,et al.Cost-effectiveness of alternative changes to a national blood collection service[J].Transfus Med,2019,29 Suppl 1,Suppl 1:42-51. [21] 蓝莎,王芮.泰勒科学管理理论在现代企业中的应用[J].现代企业,2020(9):10-11. |